-
1
المؤلفون: Ćavar Borić, Marija
المساهمون: Ljubković, Marko, Boban, Mladen, Novak Nakir, Ivana, Vrsalović, Mislav
مصطلحات موضوعية: BIOMEDICINA I ZDRAVSTVO. Kliničke medicinske znanosti. Interna medicina, Pyruvic Acid -- metabolism, Fatty Acids -- metabolism, Trimetazidine, Palmitoylcarnitine, Piruvati, Coronary Artery Disease, udc:616(043.3), Masne kiseline -- metabolizam, Pathology. Clinical medicine, Koronarna bolest, Trimetazidin, Pyruvates, Pirogrožđana kiselina -- metabolizam, BIOMEDICINE AND HEALTHCARE. Clinical Medical Sciences. Internal Medicine, Palmitoilkarnitin, Patologija. Klinička medicina
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::575c60b6ffc1f18c229e21a4040768d9Test
https://urn.nsk.hr/urn:nbn:hr:171:611120Test -
2دورية أكاديمية
-
3دورية أكاديمية
المؤلفون: E. Vershinina O., E. Salnikova S., A. Repin N., Елена Вершинина Олеговна, Елена Сальникова Сергеевна, Алексей Репин Николаевич
المصدر: The Siberian Journal of Clinical and Experimental Medicine; Том 30, № 2 (2015); 87-96 ; Сибирский журнал клинической и экспериментальной медицины; Том 30, № 2 (2015); 87-96 ; 2713-265X ; 2713-2927 ; 10.29001/2073-8552-2015-30-2
مصطلحات موضوعية: ишемическая болезнь сердца, стабильная стенокардия, чрескожные коронарные вмешательства, статины, триметазидин, coronary artery disease, stable angina, percutaneous coronary intervention, statins, trimetazidin
وصف الملف: application/pdf
العلاقة: https://cardiotomsk.elpub.ru/jour/article/view/174/175Test; Califf R.M., Abdelmeguid A.E., Kunitz R.E. et al. Myonecrosis after revascularization procedures // J. Am. Coll. Cardiol. - 1998. -Vol. 31. - P. 241-251.; Klein R.W., Kramer B.L., Howard E., Lesch M. Incidence and clinical significance of transient creatine kinase elevations and the diagnosis of non-Q wave myocardial infarction associated with coronary angioplasty // J. Am. Coll. Cardiol. - 1991. -Vol. 17. - P. 321-326.; Prasad A., Herrmann J. Myocardial Infarction due to percutaneous coronary intervention // N. Eng. J. Med. - 2011. - Vol. 364. - P 453-464.; Ellis S.G., Chew D., Chan A. et al. Death following creatine kinase-MB elevation after coronary intervention. Identification of an early risk period: importance of creatine kinase-MB level, completeness of revascularization, ventricular function and and probable benefit of statin therapy // Circulation. - 2002. -Vol. 106. - P. 1205-1211.; Ioannidis J.P.A., Karvouni E., Katritis D.G. Mortality risk conferred by small elevations of creatine-kinase MB isoenzyme after percutaneous intervention // J. Am. Coll. Cardiol. - 2003. -Vol. 42. - P. 1406-1411.; Merla R., Reddy N.K., Wang F.W. et al. Meta-analysis of published reports on the effect of statin treatment before percutaneous coronary intervention on peri-procedural myonecrosis // Am. J. Cardiol. - 2007. - Vol. 100. - P. 770-776.; Veselka J., Prochazkova S., Duchnova R. et al. Pre-procedural statin therapy reduces the risk and extent of cardiac biomarkers release following percutaneous coronary intervention // Heart Vessels. - 2006. - Vol. 21. - P. 146-151.; Jones S.P., Trocha S.D., Lefer D.J. Pretreatment with simvastatin attenuates myocardial dysfunction after ischemia and chronic reperfusion // Arterioscler. Thromb. Vasc. Biol. - 2001. -Vol. 21. - P. 2059-2064.; Bell R.M., Yellon D.M. Atorvastatin, administered at the onset of reperfusion, and independent of lipid lowering, protects the myocardium by up-regulating a pro-survival pathway // J. Am. Coll. Cardiol. - 2003. - Vol. 41. - P. 508-515.; Mensah K., Mocanu M.M., Yellon D.M: Failure to protect the myocardium against ischemia/reperfusion injury after chronic atorvastatin treatment is recaptured by acute atorvastatin treatment: a potential role for phosphatase and tensin homolog deleted on chromosome ten? // J. Am. Coll. Cardiol. - 2005. -Vol. 45. - Р 1287-1291.; Wang T., Yang Y.J., Xu B. Atorvastatin pretreatment before PCI accelerates both neointimal coverage and reendothelialization after sirolimus-eluting stent implantation using a porcine model: new findings from optical coherence tomography and pathology // J. Am. Coll. Cardiol. - 2012. - Vol. 59. - P. 1196-1209.; Davignon J. Beneficial cardiovascular pleiotropic effects of statins // Circulation. - 2004. - Vol. 109, No. 23, Suppl 1(III). -P. 39-43.; Sanguigni V., Pignatelli P., Lenti L. et al. Short-term treatment with atorvastatin reduces platelet CD40 ligand and thrombin generation in hypercholesterolemic patients // Circulation. - 2005. - Vol. 111. - P. 412-419.; Hinoi T., Matsuo S., Tadehara F. et al. Acute effect of atorvastatin on coronary circulation measured by transthoracic Doppler echocardiography in patients without coronary artery disease by angiography // Am. J. Cardiol. - 2005. - Vol. 96. - P. 89-91.; Pasceri V., Patti G., Nusca A. et al. ARMYDA Investigators. Randomized trial of atorvastatin for reduction of myocardial damage during coronary intervention: results from the ARMYDA (Atorvastatin for Reduction of Myocardial Damage during Angioplasty) study // Circulation. - 2004. - Vol. 110. - P. 674-678.; Briguori C., Visconti G., Focaccio A. et al. Novel Approches for Preventing or Limiting Events (NAPLES II) trial // J. Am. Coll. Cardiol. - 2009. - Vol. 54. - Р 2157-2163.; Sardella G., Conti G., Donahue M. et al. Rosuvastatin pretreatment in patients undergoing elective PCI to reduce the incidence of myocardial periprocedural necrosis: the ROMA trial // Catheter Cardiovasc. Interv. - 2013. - No. 81. - Р 36-43.; Patti G., Cannon C.P, Murphy S.A. et al. Clinical benefit of statin pretreatment in patients undergoing percutaneous coronary intervention. A collaborative patient-level meta-analysis of 13 randomized study // Circulation. - 2011. - Vol. 123. - Р 1622-1632.; Di Sciascio G., Patti G., Pasceri V. et al. Efficacy of atorvastatin reload in patients on chronic statin therapy undergoing percutaneous coronary intervention: results of the ARMYDA-RECAPTURE (Atorvastatin for Reduction of Myocardial Damage During Angioplasty) Randomized Trial // J. Am. Coll. Cardiol. -2009. - No. 54. - Р. 558-565.; Sardella G., Lucisano L., Mancone M. et al. Comparison of high reloading ROsuvastatin and Atorvastatin pretreatment in patients undergoing elective PCI to reduce the incidence of MyocArdial periprocedural necrosis. The ROMA II trial [Electronic resource] // Int. J. Cardiol. - 2013. - URL: http://dx.doi.org/10.1016/j.ijcard.2013.06.017Test (дата обращения 05.04.2015).; Zemanek D., Branny M., Martinkovicova L. et al. Effect of sevenday atorvastatin pretreatment on the incidence of periprocedural myocardial infarction following percutaneous coronary intervention in patients receiving long-term statin therapy. A randomized study // Inter. J. of Cardiology. - 2013. -Vol. 168. - P. 2494-2497.; Creager M.A., Luscher T.F., Cosentino F. et al. Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy // Circulation. - 2003. - Vol. 108 (12). -P. 1527-1532.; Вершинина Е.О., Репин А.Н., Рябова Т.Р. и др. Ближайшие и отдаленные результаты плановых эндоваскулярных вмешательств на коронарных артериях и влияние на них нарушений углеводного обмена // Сибирский медицинский журнал (Томск). - 2013. - Т. 28(4). - С. 28-35.; Carrozza J.P., Kuntz R.E., Levine M.J. et al. Angiographic and clinical outcome of intracoronary stenting: immediate and longterm results from a large single-center experience // J. Am. Coll. Cardiol. - 1992. - Vol. 20. - P. 328-337.; Ryden L., Grant P.J., Anker S.D. et al. ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. The Task Force on diabetes, prediabetes, and cardiovascular dis-eases of the European Society of Cardiology (ESC) and developed incollaboration with the European Association for the Study of Diabetes (EASD) // Eur. Heart J. - 2013. - Vol. 34. - P. 3035-3087.; Moses J.W., Leon M.B., Popma J.J. et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery // N. Engl. J. Med. - 2003. - Vol. 349. - P. 1315-1323.; Grube E., Silber S., Hauptmann K.E. et al. TAXUS I: six- and twelvemonth results from a randomized, double-blind trial on a slow-release paclitaxel-eluting stent for de novo coronary lesions // Circulation. - 2003. - Vol. 107. - P. 38-42.; Scrutinio D.I., Scrutinio D., Giannuzzi P. et al. Comorbidity in patients undergoing coronary artery bypass graft surgery: impact on outcome and implications for cardiac rehabilitation // European journal of cardiovascular prevention and rehabilitation: official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology. - 2008. -Vol. 15. - P 379-385.; Balakumar P., Sharma N.K. Healing the diabetic heart: Does myocardial preconditioning work? // Cellular Signalling. - 2011. - Vol. 24. - P 53-59.; Дедов И.И., Александров А.А. Диабетическое сердце: основные закономерности // Сердце. - 2004. - № 3(1). - P 5-8.; Folli F., Corradi D., Fanti P. et al. The role of oxidative stress in the pathogenesis of type 2 diabetes mellitus micro- and macrovascular complications: avenues for a mechanistic-based therapeutic approach // Curr. Diabetes Rev. - 2011. - No. 7. -P. 313-324.; Pantos C., Mourouzis I. Protection of the abnormal heart // Heart Fail Rev. - 2007. - No. 12. - P. 319-330.; Cokkinos D.V., Pantos С. Myocardial protection in man - from research concept to clinical practice // Heart Fail Rev. - 2007. - No. 12. - P. 345-362.; ВНОК. Диагностика и лечение стабильной стенокардии. Российские рекомендации (второй пересмотр) // Кардиоваскулярная терапия и профилактика. - 2008. - № 7(6), прил. 4. - P. 1-28.; Raedschelders K., Ansley D.M., Chen D.D.Y. The cellular and molecular origin of reactive oxygen species generation during myocardial ischemia and reperfusion // Pharmacol. Ther. - 2012. - Vol. 133. - P. 230-255.; Takayanagi R., Inoguchi T., Ohnaka K. Clinical and experimental evidence for oxidative stress as an exacerbating factor of diabetes mellitus // J. Clin. Biochem. Nutr. - 2011. - No. 48. -P. 72-77.; Kantor P.F., Lucien A., Kozak R. et al. The antianginal drug trimetazidine shifts cardiac energy metabolism from fatty acid oxidation to glucose oxidation by inhibiting mitochondrial long-chain 3-ketoacyl coenzyme A thiolase // Circ. Res. - 2000. - No. 86. - P. 580-588.; Ikizler M., Erkasap N., Dernek S. et al. Trimetazidine-induced enhancement of myocardial recovery during reperfusion: a comparative study in diabetic and non-diabetic rat hearts // Arch. Med. Res. - 2006. - Vol. 37(6). - P. 700-708.; Люсов В.А., Волов Н.А., Гордеев И.Г. и др. Роль миокардиальной цитопротекции в коррекции ишемического и реперфузионного повреждения миокарда у больных стабильной стенокардией, перенесших транслюминальную баллонную ангиопластику и стентирование коронарных артерий // Рос. кардиол. журнал. - 2006. - № 1. - P 33-38.; Bonello L., Sbragia P., Amabile N. et al. Protective effect of an acute oral loading dose of trimetazidine on myocardial injury following percutaneous coronary intervention // Heart. - 2007. - Vol. 93. - P. 703-707.; Iskesen I., Kurdal A.T., Eserdag M. et al. Trimetazidine may protect the myocardium during cardiac surgery // Heart Surg. Forum. -2009. - No. 12. - P. 175-179.; Labrou A., Giannoglou G., Ziotas D. et al. Trimetazidine administration minimizes myocardial damage and improves left ventricular function after percutaneous coronary intervention // Am. J. Cardiovasc. Drugs. - 2007. - No. 7. - P. 143-150.; https://cardiotomsk.elpub.ru/jour/article/view/174Test
الإتاحة: https://doi.org/10.29001/2073-8552-2015-30-2-87-96Test
https://doi.org/10.29001/2073-8552-2015-30-2Test
https://doi.org/10.1016/j.ijcard.2013.06.017Test
https://cardiotomsk.elpub.ru/jour/article/view/174Test -
4
-
5دورية أكاديمية
المؤلفون: Orhan, İsrafil, Aydın, Salih, Altın, Gökhan, Yılmaz, Fahrettin
مصطلحات موضوعية: Betahistin, Ginkgo Biloba Ekstresi, Tinnitus, Trimetazidin, Betahistine, Ginkgo Biloba Extract, Trimetazidine
وصف الملف: application/pdf
العلاقة: Kulak Burun Boğaz İhtisas Dergisi; Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı; Orhan, İ., Aydın, S., Altın, G. ve Yılmaz, F. (2013). Tinnituslu hastalarda trimetazidin, betahistin ve ginkgo biloba ekstresi etkinliğinin karşılaştırılması. Kulak Burun Boğaz İhtisas Dergisi, 23(3), 143-147. https://dx.doi.org/10.5606/kbbihtisas.2013.03064Test; https://hdl.handle.net/20.500.12511/1027Test; https://dx.doi.org/10.5606/kbbihtisas.2013.03064Test; 23; 143; 147; Q3
الإتاحة: https://doi.org/20.500.12511/1027Test
https://doi.org/10.5606/kbbihtisas.2013.03064Test
https://hdl.handle.net/20.500.12511/1027Test -
6دورية أكاديمية
مصطلحات موضوعية: ишемическая болезнь сердца, метаболическая цитопротекция, триметазидин, coronary artery disease, metabolic cytoprotection, trimetazidin
العلاقة: Катеренчук І. П. Триметазидин у комплексній терапії ішемічної хвороби серця та асоційованих кардіологічних станів / І. П. Катеренчук // Ліки України. — 2012. — № 8. — С. 20—26.; http://repository.pdmu.edu.ua/handle/123456789/4049Test
-
7
المؤلفون: Černec, Eva
المساهمون: Černe, Darko
مصطلحات موضوعية: trimetazidin, katepsin S, ishemična kardiomiopatija, udc:616.13-004.6+616.127-005.4(043.3), ranolazin, imunoterapija, ishemična bolezen srca, ateroskleroza
وصف الملف: text/url
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=od______3505::c633fa4f24b270913037485429048c00Test
https://repozitorij.uni-lj.si/IzpisGradiva.php?id=104436Test -
8رسالة جامعية
المؤلفون: Černec, Eva
المساهمون: Černe, Darko
مصطلحات موضوعية: ishemična bolezen srca, ranolazin, trimetazidin, katepsin S, imunoterapija, ateroskleroza, ishemična kardiomiopatija, info:eu-repo/classification/udc/616.13-004.6+616.127-005.4(043.3)
وصف الملف: text/url
العلاقة: https://repozitorij.uni-lj.si/IzpisGradiva.php?id=104436Test; https://repozitorij.uni-lj.si/Dokument.php?id=114959&dnTest=; https://plus.si.cobiss.net/opac7/bib/4569713?lang=slTest
-
9
المؤلفون: TURHAL, Özgül, TUTUŞ, Ahmet, KULA, Mustafa
المصدر: Volume: 2, Issue: 2 1-24
Journal of Anatolian Medical Researchمصطلحات موضوعية: Myocardial scintigraphy,viability,trimetazidine, Miyokard sintigrafisi,canlı doku,trimetazidin
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=tubitakulakb::33007539f3eb1fc8053cdb2aa8239f31Test
https://dergipark.org.tr/tr/pub/jamer/issue/31007/337064Test -
10دورية أكاديمية
المؤلفون: TURHAL, Özgül, TUTUŞ, Ahmet, KULA, Mustafa
المصدر: Volume: 2, Issue: 2 1-24 ; 2587-1153 ; Journal of Anatolian Medical Research
مصطلحات موضوعية: Myocardial scintigraphy,viability,trimetazidine, Miyokard sintigrafisi,canlı doku,trimetazidin
وصف الملف: application/pdf